Gastrin and colorectal neoplasia: Cause and effect

Digestion

Volumn 74, Issue 1, 2006, Pages 40-41

  Niv, Yaron ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ B RECEPTOR; GASTRIN; PROTON PUMP INHIBITOR;

CANCER CELL CULTURE; CANCER RISK; CELL PROLIFERATION; COLON CARCINOGENESIS; COLORECTAL CANCER; DISEASE ASSOCIATION; EDITORIAL; GENE EXPRESSION; HELICOBACTER PYLORI; HORMONE ACTION; HUMAN; HYPERGASTRINEMIA; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; STOMACH PARIETAL CELL; STOMACH SECRETION;

ADENOMA; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; COLORECTAL NEOPLASMS; GASTRINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 33751524356     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096592     Document Type: Editorial

References (12)

1. Dockray GJ, Varro A, Dimaline R, Wang T: The gastrins: their production and biological activities. Annu Rev Physiol 2001;63:119-139.
2. Noble F, Wank SA, Crawley JN, Bradwejn J, Seroogy KB, Hamon M, Roques BP: International Union of Pharmacology. XXI. Structure, distribution and functions of cholecystokinin receptors. Pharmacol Rev 1997;51:745-781.
3. Smith AM, Watson SA: Review article: gastrin and colorectal cancer. Aliment Pharmacol Ther 2000;14:1231-1247.
4. Hartwich A, Konturek SJ, Pierzchalski P, Zuchowicz M, Labza H, Konturek PC, Karczewska E, Bielanski W, Marlicz K, Starzynska T, Lawniczak M, Hahn EG: Helicobacter pylori infection, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer. Int J Colorectal Dis 2001;16:202-210.
5. Colucci R, Blandizzi C, Tanini M, Vassalle C, Breschi MC, Del Tacca M: Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production. Br J Pharmacol 2005;144:338-348.
6. Renga M, Brandi G, Paganelli G, Calabrese C, Papa S, Tosti A, Tomassetti P, Miglioli M, Biasco G: Rectal cell proliferation and colon risk in patients with hypergastrinemia. Gut 1997;41:330-332.
7. Lipkin M, Blattner W, Fraumeni JJ, Lynch H, Deschner E, Winawer S: Tritiated thymidine labeling (phi p, phi h) distribution as a marker for hereditary predisposition to colon cancer. Cancer Res 1983;43:1899-1904.
8. Clarke PA, Dickson JH, Harris JC, Grabowska A, Watson SA: Gastrin enhances the angiogenic potential of endothelial cells via modulation of heparin-binding epidermal-like growth factor. Cancer Res 2006;66:3504-3512.
9. Beales IL, Ogunwobi O: Glycine-extended gastrin inhibits apoptosis in colon cancer cells via separate activation of Akt and JNK pathways. Mol Cell Endocrinol 2006;247:140-149.
10. Ogunwobi O, Beales IL: Glycine-extended gastrin stimulates proliferation and inhibits apoptosis in colon cancer cells via cyclo-oxygenase-independent pathways. Regul Pept 2006;134:1-8.
11. Georgopoulos SD, Polymeros D, Triantafyllou K, Spiliadi C, Mentis A, Karamanolis DG, Ladas SD: Hypergastrinemia is associated with increased risk of distal colon adenomas. Digestion 2006;74:42-46.
12. Watson SA, Michaeli D, Grimes S, Morris TM, Robinson G, Varro A, Justin TA, Hardcastle JD: Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer. Cancer Res 1996;56:880-885.